Related Experiment Video
Updated: Aug 6, 2026
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Current treatment approaches to early childhood medulloblastoma
1Children's University Hospital, Josef-Schneider-Str. 2, D-97080 Wuerzburg, Germany. rutkowski@mail.uni-wuerzburg.de
Abstract:
Treatment of medulloblastoma, the most common malignant brain tumor of childhood, is particularly challenging in very young children, owing to the increased susceptibility of the immature brain to treatment-induced neurocognitive deficits. Three promising strategies have been developed in combination with systemic postoperative chemotherapy, to avoid craniospinal irradiation for young children with nonmetastatic medulloblastoma, these include: high-dose chemotherapy, with and without local radiotherapy; intraventricular chemotherapy; and local radiotherapy. More intensified strategies may be required for metastatic medulloblastoma. Future studies will clarify the prognostic relevance of desmoplasia, postoperative residual tumor and biological markers to improve stratification criteria by risk-adapted treatment recommendations. An international Phase III trial for young children with nonmetastatic medulloblastoma, comparing survival rates and neurocognitive outcomes of different treatment strategies by standardized criteria, is under discussion.
Insights
Pediatric medulloblastoma treatment in young children aims to reduce neurocognitive deficits. Strategies like high-dose chemotherapy and intraventricular chemotherapy are explored to avoid craniospinal irradiation for nonmetastatic cases.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Radiation Oncology
Background:
- Medulloblastoma is the most common malignant pediatric brain tumor.
- Treating very young children is challenging due to immature brain susceptibility to neurocognitive deficits.
- Craniospinal irradiation, a standard treatment, poses significant risks for young children.
Purpose of the Study:
- To explore strategies to avoid craniospinal irradiation in young children with nonmetastatic medulloblastoma.
- To evaluate the efficacy and safety of alternative treatment approaches.
- To improve treatment outcomes and minimize long-term side effects.
Main Methods:
- Investigating high-dose chemotherapy (with or without local radiotherapy).
- Examining intraventricular chemotherapy.
- Considering local radiotherapy as an alternative.
Main Results:
- These strategies are promising for avoiding craniospinal irradiation in select pediatric medulloblastoma cases.
- Intensified strategies may be necessary for metastatic medulloblastoma.
- Further research is needed to clarify prognostic markers for risk-adapted treatments.
Conclusions:
- Alternative treatment strategies are being developed to mitigate neurocognitive deficits in young medulloblastoma patients.
- An international Phase III trial is under discussion to compare survival and neurocognitive outcomes.
- Future studies will refine risk stratification for personalized treatment recommendations.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...